SCHEMBL22147486

SCHEMBL22147486

N#Cc1cc(N2c3ccccc3C3(c4ccccc4-c4ccccc43)c3ccccc32)ccc1-c1nc(-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 1/20 0.32
HTT P42858 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
ABCG2 Q9UNQ0 3/20 0.31
CYP19A1 P11511 1/20 0.31
AR P10275 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
GRM5 P41594 1/20 0.31
PGR P06401 1/20 0.31
HIF1A Q16665 1/20 0.30
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22147613 0.94 SMN1; SMN2 (0.36) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL22147729 0.92 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL22147618 0.91 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL22147728 0.90 HPGD (0.34) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL22147489 0.89 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL22147487 0.89 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL22147643 0.89 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL22147723 0.88 ALDH1A1 (0.32) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL22147593 0.88 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2LMNAHPGDMAPK1
SCHEMBL22147648 0.86 CYP1A2 (0.34) ALDH1A1SMN1; SMN2LMNAMAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200199149-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200199149-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND OCIAD1, OSTC, OCIAD2 ALDH1A1 104/4885SMN1; SMN2 3089/4885LMNA 3039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.